I-MED Research Institute (IMRI)
I-MED Radiology's Research Insititute is leading the radiology in new and innovative practices aimed at providing patients with better diagnostic and treatment options.
I-MED Research Institute (IMRI)
I-MED Radiology's Research Insititute is leading the radiology in new and innovative practices aimed at providing patients with better diagnostic and treatment options.
IMRI Introduction
IMRI aims to pioneer medical research within the radiology industry, leading the market in new and innovative practices. The Institute consolidates research performed across the I-MED Radiology network including investigator-initiated research projects/trials, collaborations with external partners such as universities and research organisations, and imaging/reporting services from external projects.
The IMRI concept evolved from the initial work of our accomplished research team at The Wesley Hospital and now extends to studies and projects in progress across the country.
Benefits of the I-MED Research Institute (IMRI)
- I-MED led research reaffirms I-MED's reputation as industry leaders and our standing amongst patients and referrers as Australia’s leading imaging provider.
- Findings may provide an avenue for the adaptation of new and innovative practices into standard care, of which the learnings will benefit both our patients.
- Through evidenced-based improvements in practices, I-MED will be able to provide innovative treatments and interventions for patients to ensure we continuously improve the safety and efficacy of radiology services.
- Improvement of standard care practices to extend newly developed evidence-based practices nationally to all I-MED clinics.
Recent Published Articles
- The 'Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH - PubMed
- Treatment of pulmonary artery pseudoaneurysms and stenosis with balloon‐expandable stents
- Lu177-PSMA therapy for men with advanced prostate cancer: 18 months survival analysis in a single Australian tertiary institution - PubMed
- Silicosis in artificial stone workers: Spectrum of radiological high-resolution CT chest findings - PubMed
- Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia - PubMed
- Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited - PubMed
click-hereInterested in joining us?
Are you interested in being involved in research with us? Send an email to research@i-med.com.au.